Medanta Group, one of India’s leading multi-specialty healthcare providers, is gearing up for a significant capacity boost as it pursues aggressive growth across key markets. In a recent interview, Group CEO Pankaj Sahni detailed the company’s ₹4,500-crore capital expenditure (CapEx) plan over the next five years, aimed at adding approximately 2,700 beds primarily through new greenfield hospitals while leveraging brownfield opportunities for quicker gains.
This strategic push comes as Medanta strengthens its footprint beyond its flagship facility, building on proven success in both metro and Tier-2 cities. The expansion targets new facilities in Delhi (two hospitals), Mumbai, Guwahati, and Varanasi, alongside ongoing integrations and upgrades.
Strong Financial Foundation Supports Growth
Sahni emphasized the company’s robust balance sheet as a key enabler. Medanta is currently net cash positive by nearly ₹700 crore, with healthy EBITDA-to-cash conversion. The leadership expressed high confidence in funding the entire pipeline through internal accruals, the existing balance sheet, and selective project-specific debt, without needing fresh equity raises.
“We’ve committed over the next five years approximately 4,500 crores of CapEx, and we feel very confident that this will be able to be achieved both by our balance sheet and as well as our internal accruals and any project-specific debt,” Sahni noted. The company maintains a conservative capital structure, typically targeting debt-to-equity ratios of 1:1 or lower on a project basis.
This disciplined approach draws from Medanta’s track record. Returns from the original Gurugram hospital have funded subsequent facilities, and management sees no reason this cycle of strong returns on capital won’t continue.
Phased Expansion: Brownfield First, Then Greenfield Scale-Up
In the immediate term, Medanta plans to add around 500 beds in the coming financial year through brownfield expansions across existing facilities. These additions require minimal incremental capital, allowing rapid capacity growth and operating leverage.
Longer-term, the greenfield projects will drive the bulk of the 2,700+ bed increase. Key highlights include:
- Noida: The recently launched facility (part of Phase 1 with ~300-380 operational beds out of a planned 550) is ramping up faster than expected. It has secured major insurance empanelments, including CGHS and NABH accreditation. Startup losses impacted recent margins, but these are declining monthly. The hospital is on track to turn cash positive within 3-4 months, with liver transplant programs expected soon.
- Varanasi and Others: A 400-bed multi-specialty hospital in Varanasi was announced earlier in 2026 via a built-to-suit and lease model. Similar projects are progressing in Guwahati, Mumbai, and Delhi.
Management has indicated the overall pipeline could support 2,700 to 4,000 additional beds over 3-4 years, potentially taking total network capacity toward 6,000-7,000 beds depending on execution and regulatory approvals.
Performance Backdrop and Margin Outlook
Medanta’s established hospitals in Gurugram, Lucknow, Patna, Ranchi, and Indore continue to deliver strong results, with mature assets posting margins around 26-27%. Consolidated EBITDA margins dipped in recent quarters largely due to Noida ramp-up costs but are expected to stabilize in the 24-26% range as new capacities mature and occupancy improves.
Sahni highlighted that high-quality care has proven to drive both clinical outcomes and financial returns, even in non-metro markets like Lucknow and Patna. These successes have validated the model, with competitors now entering similar markets. Group occupancy and patient volumes (both in-patient and out-patient) have shown healthy growth.
Strategic Vision: Quality Over Quantity
Medanta’s expansion is not merely about bed count but about replicating its tertiary and quaternary care expertise—anchored by advanced specialties, experienced clinical teams led by figures like Chairman Dr. Naresh Trehan, and a patient-centric approach. The company currently operates across six cities and sees ample demand for premium healthcare infrastructure.
As India’s healthcare sector benefits from rising incomes, insurance penetration, and an aging population, Medanta positions itself as a key player delivering world-class services beyond traditional metros. With a conservative yet ambitious plan, the group aims to sustain healthy returns while addressing critical gaps in advanced medical infrastructure.
Analysts and investors will watch execution closely, particularly the ramp-up of new facilities and margin recovery. If past performance is any indicator, Medanta’s blend of financial prudence and clinical excellence could fuel another phase of sustainable growth in the coming years.
(Photo courtesy: facebook/medanta)